Wells Fargo & Company Assertio Holdings, Inc. Transaction History
Wells Fargo & Company
- $429 Billion
- Q1 2025
A detailed history of Wells Fargo & Company transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 1,635 shares of ASRT stock, worth $1,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,635
Previous 1,262
29.56%
Holding current value
$1,144
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ASRT
# of Institutions
82Shares Held
27MCall Options Held
625KPut Options Held
136K-
Nantahala Capital Management, LLC New Canaan, CT8.44MShares$5.91 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$3.07 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.7MShares$1.89 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$970,3350.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.11MShares$775,3850.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $33.7M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...